Dulac Edward J III - Insider Non-Derivative Transactions at FATE THERAPEUTICS INC (FATE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 4, 2024, Dulac Edward J III's relationship to FATE THERAPEUTICS INC (FATE) is Officer (Chief Financial Officer), and currently has 101,479 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other FATE insiders.

Data Source: SEC.
Dulac Edward J III - Insider Non-Derivative Transactions of FATE Common Stock
Dulac Edward J III - Insider Non-Derivative Transactions at FATE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 5, 2024 Sell -- (Common Stock) 2447 7.77 101479
Jan 30, 2024 Sell -- (Common Stock) 1849 5 103926
Jan 10, 2024 Sell -- (Common Stock) 7028 4.37 105775
Jan 3, 2024 Sell -- (Common Stock) 5182 3.66 112803
Dec 19, 2023 Sell -- (Common Stock) 1585 3.5 117985
Aug 19, 2023 Sell -- (Common Stock) 4718 2.8 119570
Jul 6, 2023 Sell -- (Common Stock) 5182 4.83 124288
Jan 11, 2023 Sell -- (Common Stock) 7331 5.24 129470